Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

By Patrick W. Serruys, M. Morice, A. Kappetein, A. Colombo, David R. Holmes III, M. Mack, E. Ståhle, T. Feldman, M. Brand, E. Bass and 5 more. New England Journal of Medicine, 2009

4,081 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/a596afe11085e5259cccec279f0a24d0b35531fc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. B. J. Gersh
2. Judith Hochman
3. M. Creager
4. Børge G. Nordestgaard

Citations in the corpus

• Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial. (2019, methodology): “The angiographic core laboratory calculated a SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score, which indicated the degree of coronary anatomic complexity, ranged from 0 to greater than 50 for very complex lesions, and categorized patients as having lo”
• Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012, background): “The complexity of CAD and appropriate revascularization strategies in the setting of AS should be determined by consensus from interventional cardiologists and cardiovascular surgeons [15, 16].”